US Broker Ratings

UnitedHealth Group (UNH) Stock Analysis: Is There More to Gain Beyond a 2.23% Potential Upside?

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, commands a significant presence in the healthcare plans industry with a robust market capitalization of $321.06 billion. As an..

Teleflex Incorporated (TFX) Stock Analysis: Evaluating the 11.06% Potential Upside for Investors

Teleflex Incorporated (NYSE: TFX), a key player in the healthcare sector, specializes in the design, development, and supply of single-use medical devices used in critical care and surgical applications. With..

Cytokinetics (CYTK) Stock Analysis: A 25.75% Potential Upside with Innovative Muscle Treatments

Cytokinetics, Incorporated (NASDAQ: CYTK) is capturing the attention of investors with its promising therapeutic pipeline and a notable 25.75% potential upside based on analyst projections. With a market capitalization of..

Krystal Biotech (KRYS) Stock Analysis: A 13% Upside Potential Amid Strong Revenue Growth

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the healthcare sector, particularly within the biotechnology industry. Headquartered in Pittsburgh, Pennsylvania, the company is rapidly gaining investor attention with its..

Novartis AG (NVS) Stock Analysis: Navigating a 3.07% Dividend Yield Amidst Market Volatility

Novartis AG (NVS), a Swiss healthcare giant, commands a market capitalization of $252 billion and operates in the drug manufacturing sector. While the company is a formidable player in the..

DexCom, Inc. (DXCM) Stock Analysis: A 53% Upside Potential with Strong Buy Ratings

DexCom, Inc. (DXCM), a prominent player in the healthcare sector specializing in medical devices, has captured investor attention with its innovative continuous glucose monitoring (CGM) systems. Operating within the United..

Chemed Corp (CHE) Stock Analysis: Healthcare Giant with a 34.53% Potential Upside

Chemed Corp (CHE) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Cincinnati, Ohio, the company operates through two primary segments: VITAS,..

Agilent Technologies, Inc. (A) Stock Analysis: Potential 8.16% Upside and Robust Revenue Growth

Agilent Technologies, Inc. (NYSE: A) presents a compelling opportunity for investors interested in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $38.73 billion,..

Bio-Techne Corp (TECH) Investor Outlook: Navigating Growth with a 13.65% Potential Upside

Bio-Techne Corp (NASDAQ: TECH) stands out in the biotechnology sector with a robust market capitalization of $9.13 billion. As a prominent player in the healthcare industry, Bio-Techne develops and manufactures..

AstraZeneca PLC (AZN) Stock Analysis: 6.2% Potential Upside Fuels Investor Interest

AstraZeneca PLC (AZN), a stalwart in the healthcare sector, continues to capture investor attention with its robust market position and promising growth potential. Headquartered in Cambridge, United Kingdom, AstraZeneca is..

Baxter International Inc. (BAX) Stock Analysis: A 27.56% Potential Upside with Dividend Yield of 3.10%

Baxter International Inc. (NYSE: BAX) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $11.27 billion, the..

RadNet, Inc. (RDNT) Stock Analysis: Healthcare Diagnostics Firm Poised for Growth with a 12.3% Upside Potential

RadNet, Inc. (NASDAQ: RDNT) stands out in the healthcare diagnostics sector, offering promising growth potential for investors with a recent analyst consensus indicating a potential upside of 12.3%. For investors..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Biotech Terrain with a 68.40% Revenue Growth

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, continues to capture investor interest with its innovative approach to treating rare diseases. Headquartered in Cambridge, Massachusetts, this commercial-stage..

Option Care Health, Inc. (OPCH) Investor Outlook: Analyzing a 41.89% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a key player in the healthcare sector, specifically in medical care facilities, presents an intriguing opportunity for investors seeking growth in a dynamic market...

West Pharmaceutical Services (WST) Stock Analysis: Exploring a 21% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector, has garnered significant attention from investors, and for compelling reasons. With a market capitalization of $18.82 billion,..

Regeneron Pharmaceuticals (REGN) Stock Analysis: A 27.79% Upside Beckons Investors Amidst Biotechnology Innovations

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a heavyweight in the biotechnology sector, offers a compelling narrative for investors seeking exposure to groundbreaking medical innovations. With a market capitalization of $59.84 billion,..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 31% Upside Potential in Transforming Organ Transplantation

TransMedics Group, Inc. (NASDAQ: TMDX), a prominent player in the healthcare sector, is pioneering advancements in organ transplant therapy. With a current market capitalization of $3.66 billion, this Massachusetts-based medical..

Teva Pharmaceutical Industries (TEVA) Rating Update: Assessing a Strong Buy Consensus Amidst a 22% Upside Potential

Teva Pharmaceutical Industries (NYSE: TEVA), a stalwart in the global healthcare arena, has long been a critical player in the specialty and generic drug manufacturing sector. With its roots in..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unpacking a 19.97% Potential Upside for Savvy Investors

Stevanato Group S.p.A. (NYSE: STVN) is making waves in the healthcare sector, particularly in the Medical Instruments & Supplies industry. This Italy-based company, with a robust market capitalization of $6.51..

Insulet Corporation (PODD) Stock Analysis: Exploring a 15.3% Potential Upside with Robust Growth Prospects

Investors looking to capitalize on the growing demand for innovative medical devices might find Insulet Corporation (NASDAQ: PODD) an intriguing prospect. With a market capitalization of $22.14 billion, Insulet operates..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds